An investor whose firm has raised $1.8 billion to invest in biotech explains why we're seeing so… [Video]

Cristian WorthingtonFeedToPost, MediaVidi Twitter

To see the original post and the Video, click here

Reuters Money is flowing into biotech startups, with companies increasingly raising more than $100 million in early-stage funding rounds.Steve Elms, a managing partner at Aisling Capital, which invests in certain private and public life-sciences companies, says there are a few reasons we"ve been...

Watch/Read More


Reuters
  • Money is flowing into biotech startups, with companies increasingly raising more than $100 million in early-stage funding rounds.
  • Steve Elms, a managing partner at Aisling Capital, which invests in certain private and public life-sciences companies, says there are a few reasons we’ve been seeing these massive funding rounds.
  • Those include early-stage venture funds having more cash, …

Funding has been flowing into biotech over the past few years.

Over one week earlier this year, biotech and healthcare startups raised

How to Automate Video Content Marketing in Under 1 Hour

Day 0

5 Easy Video Lessons +
Bonus Free Toolkit

Powered by ConvertKit